{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:57:52Z","timestamp":1778511472832,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.drugalcdep.2015.09.031","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T05:00:47Z","timestamp":1445403647000},"page":"179-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Safety of oral dronabinol during opioid withdrawal in humans"],"prefix":"10.1016","volume":"157","author":[{"given":"Crystal J.","family":"Jicha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle R.","family":"Lofwall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Nuzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanna","family":"Babalonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy Claude","family":"Elayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon L.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0005","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1369-1600.2011.00427.x","article-title":"Subjective, cognitive and cardiovascular dose\u2013effect profile of nabilone and dronabinol in marijuana smokers","volume":"18","author":"Bedi","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0010","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/cpt1979254440","article-title":"Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms","volume":"25","author":"Benowitz","year":"1979","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2015.05.013","article-title":"The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone","volume":"154","author":"Bisaga","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0020","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1124\/jpet.102.046870","article-title":"Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral delta 9-tetrahydrocannabinol","volume":"305","author":"Cichewicz","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0025","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.npp.1301243","article-title":"Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers","volume":"32","author":"Haney","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0030","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.CIR.53.4.703","article-title":"The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade","volume":"53","author":"Kanakis","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0035","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-3565(24)29469-6","article-title":"Opioid and cannabinoid modulation of precipitated withdrawal in delta (9)-tetrahydrocannabinol and morphine-dependent mice","volume":"298","author":"Lichtman","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl. A","key":"10.1016\/j.drugalcdep.2015.09.031_bib0040","doi-asserted-by":"crossref","first-page":"15A","DOI":"10.1155\/2005\/242516","article-title":"Pharmacokinetics of cannabinoids","volume":"10","author":"McGilveray","year":"2005","journal-title":"Pain Res. Manage."},{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.bjp.0707261","article-title":"Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions","volume":"151","author":"Mendizabal","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0050","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1097\/00001756-199810260-00012","article-title":"CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats","volume":"9","author":"Navarro","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuroscience.2004.05.015","article-title":"Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens","volume":"127","author":"Pickel","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2009.11.023","article-title":"Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors","volume":"1312","author":"Scavone","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0065","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuroscience.2013.04.034","article-title":"Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal","volume":"248","author":"Scavone","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0070","article-title":"Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/09540260902782794","article-title":"Interaction of the cannabinoid and opioid systems in the modulation of nociception","volume":"21","author":"Welch","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.09.031_bib0080","first-page":"171","article-title":"A new face of endocannabinoids in pharmacotherapy, Part I: Protective role of endocannabinoids in hypertension and myocardial infarction","volume":"65","author":"Zubrzycki","year":"2014","journal-title":"J. Physiol. Pharmacol."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161501683X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161501683X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T02:48:13Z","timestamp":1748659693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687161501683X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":16,"alternative-id":["S037687161501683X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.09.031","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of oral dronabinol during opioid withdrawal in humans","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}